Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.22.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule Share Based Compensation Expenses
Stock-based compensation expense is principally related to awards issued pursuant to the Legacy Innovid Stock Option Plan (“Legacy Plan”) and 2021 Innovid Corp. Incentive Plan (“2021 Plan”) and is summarized as follows:

Three months ended March 31,

2022 2021
(Unaudited) (Unaudited)
Cost of goods sold
$ 105  $
Research and development
479  51 
Sales and marketing
580  87 
General and administrative
399  118 
Total
$ 1,563  $ 261 
Share-based Payment Arrangement, Option, Activity
A summary of the employees’ stock option activity under the Legacy Plan for the three months ended March 31, 2022 is as follows:

Three months ended March 31, 2022
(Unaudited)

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of period
11,122,648  $ 0.82  6.87 $ 64,818 
Transfer between employee and consultant 40,118  0.64 
Granted in acquisition 949,893  0.31 
Forfeited (16,053) 1.81 
Expired (7,830) 0.61 
Exercised (1,452,971) 0.30 
Outstanding at end of period
10,635,805  $ 0.84  7.70 $ 55,276 
Exercisable options at end of period
7,122,369  $ 0.56  7.25 $ 39,000 
A summary of the consultants’ stock option activity under the Legacy Plan for the three months ended March 31, 2022 is as follows:

Three months ended March 31, 2022
(Unaudited)

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of period
179,627  $ 0.31  2.34 $ 1,139 
Transfer between employee and consultant (40,118) 0.64 
Exercised (69,298) 0.30 
Outstanding at end of period
70,211  $ 0.49  5.01 $ 390 
Exercisable options at end of period
60,516  $ 0.45  4.49 $ 338